{"transactions":[{"id":1610249,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-29T21:01:05.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2025, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":85000,"derivative":{"exercise_price":30.3,"expiration_date":"2034-02-27","underlying":"Ordinary Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000905148-24-000834","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000090514824000834/form4.xml","form_type":"4"}},{"id":1675387,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T18:30:33.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000149315224003111/ownership.xml","form_type":"4"}},{"id":1782186,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-13T19:33:17.000Z","date":"2023-09-13","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":192000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000905148-23-000919","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000090514823000919/form4.xml","form_type":"4"}},{"id":1782185,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-09-13T19:33:17.000Z","date":"2023-09-13","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":55.4761,"value":110952.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $54.995 to $55.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-000919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000090514823000919/form4.xml","form_type":"4"}},{"id":1782184,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-09-13T19:33:17.000Z","date":"2023-09-13","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":24.9,"value":49800.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000905148-23-000919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000090514823000919/form4.xml","form_type":"4"}},{"id":1806066,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T21:15:35.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":194000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001140361-23-040143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123040143/form4.xml","form_type":"4"}},{"id":1806065,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-16T21:15:35.000Z","date":"2023-08-16","kind":"sale","planned":true,"acquired":false,"shares":374,"price":59.7365,"value":22341.451,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $59.65 to $60.26, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-040143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123040143/form4.xml","form_type":"4"}},{"id":1806064,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-16T21:15:35.000Z","date":"2023-08-16","kind":"sale","planned":true,"acquired":false,"shares":748,"price":58.9294,"value":44079.1912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $58.585 to $59.24, inclusive."}],"balance_after":374,"source":{"system":"sec-edgar","filing":"0001140361-23-040143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123040143/form4.xml","form_type":"4"}},{"id":1806063,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-16T21:15:35.000Z","date":"2023-08-16","kind":"sale","planned":true,"acquired":false,"shares":878,"price":58.1542,"value":51059.3876,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $57.555 to $58.545, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4."}],"balance_after":1122,"source":{"system":"sec-edgar","filing":"0001140361-23-040143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123040143/form4.xml","form_type":"4"}},{"id":1806062,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-08-16T21:15:35.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":24.9,"value":49800.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001140361-23-040143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123040143/form4.xml","form_type":"4"}},{"id":1830993,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T20:45:40.000Z","date":"2023-07-12","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":196000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001140361-23-034304","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123034304/form4.xml","form_type":"4"}},{"id":1830992,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-07-12T20:45:40.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":92,"price":68.1957,"value":6274.0044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $68.12 to $68.20, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-034304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123034304/form4.xml","form_type":"4"}},{"id":1830991,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-07-12T20:45:40.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":1908,"price":67.4804,"value":128752.6032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $66.94 to $67.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":92,"source":{"system":"sec-edgar","filing":"0001140361-23-034304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123034304/form4.xml","form_type":"4"}},{"id":1830990,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-07-12T20:45:40.000Z","date":"2023-07-12","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":24.9,"value":49800.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001140361-23-034304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123034304/form4.xml","form_type":"4"}},{"id":1852585,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T19:31:56.000Z","date":"2023-06-16","kind":"exercise","planned":true,"acquired":false,"shares":7331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":198000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":7331},"source":{"system":"sec-edgar","filing":"0001140361-23-030333","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123030333/form4.xml","form_type":"4"}},{"id":1852584,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-16T19:31:56.000Z","date":"2023-06-16","kind":"sale","planned":true,"acquired":false,"shares":7331,"price":74,"value":542494.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-030333","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123030333/form4.xml","form_type":"4"}},{"id":1852583,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-16T19:31:56.000Z","date":"2023-06-16","kind":"exercise","planned":true,"acquired":true,"shares":7331,"price":24.9,"value":182541.9,"ownership":{"direct":true},"balance_after":7331,"source":{"system":"sec-edgar","filing":"0001140361-23-030333","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123030333/form4.xml","form_type":"4"}},{"id":1856061,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T21:15:42.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":false,"shares":4669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":205331,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":4669},"source":{"system":"sec-edgar","filing":"0001140361-23-029929","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123029929/form4.xml","form_type":"4"}},{"id":1856060,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-14T21:15:42.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":655,"price":75.4858,"value":49443.199,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $75.26 to $76.20, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-029929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123029929/form4.xml","form_type":"4"}},{"id":1856059,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-14T21:15:42.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":2534,"price":74.5895,"value":189009.793,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $74.16 to $75.13, inclusive."}],"balance_after":655,"source":{"system":"sec-edgar","filing":"0001140361-23-029929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123029929/form4.xml","form_type":"4"}},{"id":1856058,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-14T21:15:42.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":971,"price":73.3098,"value":71183.8158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $73.03 to $73.995, inclusive."}],"balance_after":3189,"source":{"system":"sec-edgar","filing":"0001140361-23-029929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123029929/form4.xml","form_type":"4"}},{"id":1856057,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-14T21:15:42.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":509,"price":72.4539,"value":36879.0351,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $71.96 to $72.91, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 5 of this Form 4."}],"balance_after":4160,"source":{"system":"sec-edgar","filing":"0001140361-23-029929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123029929/form4.xml","form_type":"4"}},{"id":1856056,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-06-14T21:15:42.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":true,"shares":4669,"price":24.9,"value":116258.1,"ownership":{"direct":true},"balance_after":4669,"source":{"system":"sec-edgar","filing":"0001140361-23-029929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123029929/form4.xml","form_type":"4"}},{"id":1947416,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-17T21:30:19.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":210000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-23-005288","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761923005288/doc1.xml","form_type":"4"}},{"id":1947415,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-03-17T21:30:19.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":6000,"price":48.6616,"value":291969.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $48.44 to $49.06, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-23-005288","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761923005288/doc1.xml","form_type":"4"}},{"id":1947414,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-03-17T21:30:19.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":6000,"price":48.161,"value":288966.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $47.43 to $48.42, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001567619-23-005288","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761923005288/doc1.xml","form_type":"4"}},{"id":1947413,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-03-17T21:30:19.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":12000,"price":24.9,"value":298800.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001567619-23-005288","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761923005288/doc1.xml","form_type":"4"}},{"id":1974562,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T21:30:34.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":48000,"derivative":{"exercise_price":52.97,"expiration_date":"2033-03-02","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001140361-23-010182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036123010182/form4.xml","form_type":"4"}},{"id":2068441,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T08:30:22.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 2,000 shares of Common Stock and an accompanying warrant to purchase 1,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":1000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-23-000223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000149315223000223/ownership.xml","form_type":"4"}},{"id":2068440,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T08:30:22.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 2,000 shares of Common Stock and an accompanying warrant to purchase 1,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001493152-23-000223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000149315223000223/ownership.xml","form_type":"4"}},{"id":2098534,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-02T21:30:29.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":222000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001140361-22-044320","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122044320/form4.xml","form_type":"4"}},{"id":2098533,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-02T21:30:29.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":4000,"price":62.51,"value":250040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-22-044320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122044320/form4.xml","form_type":"4"}},{"id":2098532,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-02T21:30:29.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":4000,"price":24.9,"value":99600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001140361-22-044320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122044320/form4.xml","form_type":"4"}},{"id":2125854,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-03T21:30:27.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":226000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001140361-22-039910","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122039910/form4.xml","form_type":"4"}},{"id":2125853,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-03T21:30:27.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":511,"price":62.4109,"value":31891.9699,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $62.22 to $62.59, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-22-039910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122039910/form4.xml","form_type":"4"}},{"id":2125852,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-03T21:30:27.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":3489,"price":61.8179,"value":215682.6531,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $61.21 to $62.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4."}],"balance_after":511,"source":{"system":"sec-edgar","filing":"0001140361-22-039910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122039910/form4.xml","form_type":"4"}},{"id":2125851,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-03T21:30:27.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":4000,"price":24.9,"value":99600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001140361-22-039910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122039910/form4.xml","form_type":"4"}},{"id":2142358,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T21:46:48.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":230000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001567619-22-018292","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922018292/doc1.xml","form_type":"4"}},{"id":2142357,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-05T21:46:48.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":4000,"price":60.9,"value":243600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-018292","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922018292/doc1.xml","form_type":"4"}},{"id":2142356,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-05T21:46:48.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":4000,"price":24.9,"value":99600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001567619-22-018292","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922018292/doc1.xml","form_type":"4"}},{"id":2157502,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-16T21:32:09.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":234000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001567619-22-017567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922017567/doc1.xml","form_type":"4"}},{"id":2157501,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-09-16T21:32:09.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":4000,"price":30,"value":120000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-017567","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922017567/doc1.xml","form_type":"4"}},{"id":2157500,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-09-16T21:32:09.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":4000,"price":24.9,"value":99600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001567619-22-017567","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922017567/doc1.xml","form_type":"4"}},{"id":2195992,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-03T21:39:49.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":238000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001567619-22-014909","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922014909/doc1.xml","form_type":"4"}},{"id":2195991,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-03T21:39:49.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":4000,"price":30.52,"value":122080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-014909","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922014909/doc1.xml","form_type":"4"}},{"id":2195990,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-08-03T21:39:49.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":4000,"price":24.9,"value":99600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001567619-22-014909","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922014909/doc1.xml","form_type":"4"}},{"id":2210014,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-08T21:34:50.000Z","date":"2022-07-06","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":242000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001567619-22-013840","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922013840/doc1.xml","form_type":"4"}},{"id":2210013,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-07-08T21:34:50.000Z","date":"2022-07-06","kind":"sale","acquired":false,"shares":8000,"price":30,"value":240000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-013840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922013840/doc1.xml","form_type":"4"}},{"id":2210012,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-07-08T21:34:50.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":8000,"price":24.9,"value":199200.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001567619-22-013840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761922013840/doc1.xml","form_type":"4"}},{"id":2372416,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T21:31:19.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 23, 2023 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":85000,"derivative":{"exercise_price":32.45,"expiration_date":"2032-02-23","underlying":"Ordinary Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001140361-22-006895","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000114036122006895/form4.xml","form_type":"4"}},{"id":2754559,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":93713,"kind":"person","name":"Garren Hideki","position":1,"cik":"0001854126","reported_name":"Garren Hideki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-07T17:41:32.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":24.9,"expiration_date":"2031-04-05","underlying":"Ordinary Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001567619-21-007776","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854126/000156761921007776/doc1.xml","form_type":"4"}}]}